Viewing Study NCT04944069


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2026-02-21 @ 9:06 PM
Study NCT ID: NCT04944069
Status: UNKNOWN
Last Update Posted: 2021-06-29
First Post: 2021-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis
Sponsor: Second Affiliated Hospital of Nanchang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module